This company has shut down. Hermes Life Sciences is no longer operating — its last tracked round was a Grant in 2021.
Explore the Startup GraveyardHermes Life Sciences develops solutions to improve the accuracy and accessibility of blood testing at the point-of-care.
Hermes Life Sciences has raised $925K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
Hermes Life Sciences's investors include National Science Foundation.
Hermes Life Sciences is headquartered in Rockville, United States.
Hermes Life Sciences develops solutions to improve the accuracy and accessibility of blood testing at the point-of-care.
Hermes Life Sciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hermes Life Sciences — Funding & Investors." VCBacked, August 1, 2021, https://www.vcbacked.co/company/hermes-life-sciences. Accessed September 8, 2026.
VCBacked. (2021). Hermes Life Sciences — Funding & Investors. Retrieved September 8, 2026, from https://www.vcbacked.co/company/hermes-life-sciences
{{cite web |title=Hermes Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/hermes-life-sciences |website=VCBacked |access-date=September 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated